Caris Life Sciences Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 5, 2026, Caris Life Sciences, Inc. (CAI) announced its financial results for the quarter ended June 30, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to its Current Report on Form 8-K (Item 2.02: Results of Operations and Financial Condition).
• The Form 8-K was signed on August 5, 2026 by Luke Power, Senior Vice President, Chief Financial Officer and Chief Accounting Officer.

Key Details

• Press release date: August 5, 2026.
• Reporting period: quarter ended June 30, 2026.
• Disclosure type: Item 2.02 filing of quarterly results; press release furnished as Exhibit 99.1 and incorporated by reference.
• Form 8-K executed by Luke Power (SVP, CFO & CAO) on August 5, 2026.

Why It Matters

• This filing notifies investors that Caris has released its latest quarterly results—key information (earnings, revenue, margins, and any management commentary or guidance) that can affect the stock.
• The Form 8-K itself does not include the financial detail in-line; investors should read the attached press release (Exhibit 99.1) and any forthcoming periodic reports (e.g., 10-Q) for the full numbers and context.